downside to glp-1 The Pros and Cons of GLP Medications for Weight Optimization The GLP-1 revolution: What UAB
Description
Obesity is now very common among patients with Crohns disease, yet there is limited guidance on how newer metabolic medications, particularly GLP-1 receptor agonists affect Crohns-related outcomes, presenting author Nakul Ganju, MD, an internal medicine resident at Howard University Hospital in Washington, DC, told GI & Hepatology News
When the drug became extremely popular, pharma companies didnt know what to do
Two authors (AM and SS) independently screened study titles and abstracts to ascertain eligibility for full-text assessment, with any discrepancies resolved through consultation with a senior author (HR)
If you want quicker results, injectable semaglutide may be a more effective option
